DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Several potential prognostic factors are available today for patients with breast cancer, and many more are being identified and studied.
To evaluate the clinical utility of these factors, it will be necessary to measure them on a large number of patients, and then follow these patients so that multivariate survival analyses can be performed.
The Oncology Research Network was established in 1986 by the University of Texas Health Science Center at San Antonio and Nichols Institute Reference Laboratories in order to evaluate the clinical utility of new prognostic factors for patients with primary breast cancer.
The first generation of prognostic factors included steroid receptors, along with DNA ploidy and S-phase fraction determined by flow cytometry.
Mots-clés Pascal : Pronostic, Récepteur biologique, Stéroïde, Phase S, Ploïdie, DNA, Tumeur maligne, Glande mammaire, Cytométrie flux, Femelle, Homme, Epidémiologie, Glande mammaire pathologie
Mots-clés Pascal anglais : Prognosis, Biological receptor, Steroid, S Phase, Ploidy, DNA, Malignant tumor, Mammary gland, Flow cytometry, Female, Human, Epidemiology, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0132826
Code Inist : 002B20E02. Création : 199406.